ArticleInternational journal of molecular sciences2025

Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice.

Peter Krüger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.